VFG
GSK icon

Victory Financial Group’s GSK GSK Stock Holding History

Victory Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$613K Buy
11,703
+4,132
+55% +$219K 0.06% 188
2026
Q1 		$418K Sell
7,571
-3,046
-29% -$165K 0.05% 214
2025
Q4 		$521K Buy
10,617
+4,731
+80% +$221K 0.07% 183
2025
Q3 		$254K Buy
+5,886
New +$230K 0.03% 213

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Victory Financial Group's GSK Position: Q2 2026 in Review

Victory Financial Group increased its GSK (GSK) stake by 55% in Q2 2026, buying an estimated $219K and bringing the position to 11,703 shares worth $613K. The position accounts for 0.06% of the portfolio, ranked #188.

Victory Financial Group first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Victory Financial Group held 11,703 shares of GSK worth $613K as of Q2 2026.
  • Victory Financial Group bought 4,132 GSK shares in Q2 2026, an estimated $219K.
  • GSK made up 0.06% of Victory Financial Group's portfolio in Q2 2026, its #188 holding.
  • Victory Financial Group first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Victory Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.